Home|Journals|Articles by Year|Audio Abstracts

Original Article

J App Pharm Sci. 2023; 13(4): 141-148

Chitosan-tripolyphosphate nanoparticles encapsulated rutin targeting bacterial growth inhibition and its cytotoxicity on PANC-1 pancreatic adenocarcinoma cell

K. T. Ramya Devi, Shalini James Paulraj, Yashesh Shah, Santhosh Raja Kumar, Priyatharcini Kejamurthy.

Cited by 0 Articles

Nano-carrier systems are highly explored for the slow release of a drug. Chitosan (CS), a polymer, has more applications in nano-drug carrier systems. To explore these applications, currently, we synthesized CS nanoparticles (CS-NPs), and it was allowed to encapsulate free Rutin (RUT) and it resulting in CS-NPs/RUT. Further, it was characterized, and the size of CS-NPs was found to be 79 nm, and upon encapsulating RUT, the particle size was increased to 173 nm, which resulted in CS-NPs/RUT. The entrapment of RUT with CS-NPs was found to be -85%. MTT-based cytotoxicity assay represented the non-lethal nature of CS-NPs/RUT toward normal osteoblast cells, C3H10T1/2 clone8, and showed cytotoxicity against pancreatic adenocarcinoma cells, PANC-1. Furthermore, we extended the study to analyze bacterial growth inhibition and incorporation by CS-encapsulated RUT. It was performed through flow cytometry in different concentrations of 100, 200, and 300 μg/ml of treatments in Escherichia coli. The bacterial inhibition and incorporation of bacteria were significantly higher in CS-NPs/RUT compared with RUT. Hence, the experiments depicted the superiority of CS-NPs/RUT over free RUT that suggested, CS encapsulation as an efficient system for delivering RUT for bacterial growth inhibition and also anti-cancer cell proliferation.

Key words: Chitosan, Rutin, PANC-1, C3H10T1/2, Tripolyphosphate, pancreatic cancer

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.